Institute of Liver and Biliary Sciences
New Delhi, National Capital Territory of Delhi, 110070, India
NCT Number: NCT04112004
We analyzed the association of delta sodium levels with their effect on post liver transplant outcomes in consecutive patients undergoing liver transplantation. Records were analyzed for electrolytes and outcome measures, and data was analyzed.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
New Delhi, National Capital Territory of Delhi, 110070, India
Preoperative hyponatremia was identified in patients. The mean change in sodium in hyponatremic patients was compared with inpatients with normal sodium levels. The impact of the delta sodium levels with short-term outcomes, such as duration of intubation, intensive care unit length of stay were analyzed with univariate and multivariate logistic regression analyses.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 day
difference between baseline and postoperative sodium in liver transplant recipients
Time frame: 1 month
post transplant mortality after liver transplantation
Time frame: 1 month
Post operative neurological complications after liver transplantation
Time frame: 1 month
duration of mechanical ventilation after liver transplantation
Time frame: 1 month
Hospital stay after liver transplantation
Time frame: 1 month
Duration of ICU stay after liver transplantation
Institute of Liver and Biliary Sciences, India
Other
Effect of Perioperative Delta Sodium on Outcomes in Liver Transplant Recipients
Acronym: SOLT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04853641
Liver Transplant; Complications, Pathologic Processes
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT07362745
Digestive System Diseases, End Stage Liver Disease
Xi'an, Shaanxi, China
View Trial DetailsNCT04188717
Liver Transplant; Complications, Neurologic Complication
View Trial DetailsNCT05818644
Hematologic Diseases, Hemic and Lymphatic Diseases
Groningen, Netherlands
View Trial Details